Saturday, August 29, 2015 10:57:04 AM
http://investorshub.advfn.com/Bio-Matrix-Scientific-Group-Inc-BMSN-6801/?NextStart=80120
Billions and Billions of Shares Diluted since then....
http://ih.advfn.com/p.php?pid=nmona&article=68130817
There were 4,232,931,245 shares of Common Stock outstanding as of June 30, 2015.
~~~ Now Koos, aka"Dr. Dilutions," is moving all the Bills from Over-Diluted BMSN to RGBP!!
The MONTHLY Rent Payments to ENTB for $5000,,, & to Thomas Ichim shall be paid salary at the rate of $10,000 per month,, & Christine Ichim shall be paid salary at the rate of $6,000 per month,, are NOT Restricted Shares!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116550717
...and Don't forget the Thousands & Thousands going Out each Month to Pay David Koos and Todd S. Caven , who serve as the Company's Principal Executive Officer and Principal Financial Officer!!
http://ih.advfn.com/p.php?pid=nmona&article=67931748
O/S keeps Grow'n Monthy!
..so Sad!
& these New Dilutions Transferred to RGBP, Also!
8k = http://ih.advfn.com/p.php?pid=nmona&article=68309040&symbol=RGBP
On August 1, 2015 that agreement for a license grant of intellectual property to Regen Biopharma,Inc. (“Regen”) by Benitec Australia Limited (“Benitec”) dated August 5, 2013 (“Agreement”) was amended as follows:
Any License Fees or Milestone Payments ( as those terms are defined in the Agreement”) to be paid subsequent to April 6, 2015 may be paid in the common stock of Regen.
...so sad!
such common stock would be issued at Regen Biopharma’s discretion and, in the event that Regen Biopharma doesn’t have enough authorized shares available to issue, Regen Biopharma may increase the authorized shares so as to allow payment to Benitec Australia.
OOOuch!
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
